The meeting called for a thorough investigation on possible misconduct in the regulation and supervision. Any dereliction of duty will be investigated and once established, severely punished. There will be zero tolerance for law-breaking activities such as bribe-taking and illegal transfer of benefits.

 

"Possible criminal activities of counterfeiting and administrative dereliction of duty will be thoroughly investigated and punished with the full rigor of the law. We must make this amply clear to our people and to the international community," Li noted at the meeting.

 

The Monday meeting also urged competent government agencies to move quickly in formulating a detailed regulatory plan that covers the entire process of vaccine R&D, production, distribution and use to set up institutional safeguards for drug safety

 

"As part of efforts to handle this incident, we must carry out sweeping checks on the vaccine business and indeed the entire drug industry, and put together a long-term mechanism for drug safety by drawing on advanced international practice," Li said.

 

He instructed that detailed and sound plans be worked out to deal with problems arising from the incident.